Clinical Trial Update: Safety Study of Regorafenib and SIR-Spheres® Microspheres Radioembolization in Patients With Refractory Metastatic Colorectal Cancer With Liver Metastases [Phase 2]

View source ↗

Summary

Phase 2 safety study evaluating regorafenib in combination with SIR-Spheres microspheres for refractory metastatic colorectal cancer with liver metastases has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Liver Metastases

Drugs mentioned

• Regorafenib (regorafenib)
• SIR-Spheres Microspheres (yttrium-90 resin microspheres)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Colorectal Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2018-07-12